Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

Viking accelerates development of obesity drug that could rival Wegovy, Zepbound

Viking Therapeutics plans to move its injectable obesity treatment into a Phase 3 study faster than expected, bringing the biotech closer to joining the highly

July 24, 2024

Lantheus hands Perspective Therapeutics $28M upfront to expand its radiopharma options

Radiopharma company Lantheus is looking to build up its portfolio through a collaboration with Perspective Therapeutics. By handing Perspective $28 million upfront, Lantheus has the

January 10, 2024

AI Governance Alliance calls for better collaboration in advanced AI

Share this article Ai Needs Stronger Collaboration, Says Aiga Credit: Getty Images / Andreypopov As global leaders and industry power players gather in Davos to

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.